vs
CuriosityStream Inc.(CURI)与KESTRA MEDICAL TECHNOLOGIES, LTD.(KMTS)财务数据对比。点击上方公司名可切换其他公司
KESTRA MEDICAL TECHNOLOGIES, LTD.的季度营收约是CuriosityStream Inc.的1.2倍($22.6M vs $19.2M),CuriosityStream Inc.净利率更高(-19.7% vs -145.3%,领先125.6%),CuriosityStream Inc.自由现金流更多($3.9M vs $-25.6M)
CuriosityStream是来自美国的流媒体订阅点播服务商,主打纪实类影视内容,涵盖纪录片长片、系列纪实节目与电视栏目。除了品牌同名的视频点播订阅服务外,该公司还开设了Curiosity纪实线性电视频道,目前已接入FuboTV、Roku频道等多个平台。
Kestra Medical Technologies(KMTS)是一家专注于微创医疗器械研发、生产与商业化的医疗科技企业,核心产品覆盖介入心脏病学与结构性心脏病治疗领域,市场覆盖北美、欧洲及亚太重点区域,服务全球医疗机构与患者。
CURI vs KMTS — 直观对比
营收规模更大
KMTS
是对方的1.2倍
$19.2M
净利率更高
CURI
高出125.6%
-145.3%
自由现金流更多
CURI
多$29.6M
$-25.6M
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $19.2M | $22.6M |
| 净利润 | $-3.8M | $-32.8M |
| 毛利率 | — | 50.6% |
| 营业利润率 | -17.6% | -140.7% |
| 净利率 | -19.7% | -145.3% |
| 营收同比 | 35.8% | — |
| 净利润同比 | -34.6% | — |
| 每股收益(稀释后) | $-0.07 | $-0.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CURI
KMTS
| Q4 25 | $19.2M | $22.6M | ||
| Q3 25 | $18.4M | $19.4M | ||
| Q2 25 | $19.0M | — | ||
| Q1 25 | $15.1M | — | ||
| Q4 24 | $14.1M | — | ||
| Q3 24 | $12.6M | — | ||
| Q2 24 | $12.4M | — | ||
| Q1 24 | $12.0M | — |
净利润
CURI
KMTS
| Q4 25 | $-3.8M | $-32.8M | ||
| Q3 25 | $-3.7M | $-25.8M | ||
| Q2 25 | $784.0K | — | ||
| Q1 25 | $319.0K | — | ||
| Q4 24 | $-2.8M | — | ||
| Q3 24 | $-3.1M | — | ||
| Q2 24 | $-2.0M | — | ||
| Q1 24 | $-5.0M | — |
毛利率
CURI
KMTS
| Q4 25 | — | 50.6% | ||
| Q3 25 | — | 45.7% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率
CURI
KMTS
| Q4 25 | -17.6% | -140.7% | ||
| Q3 25 | -24.5% | -149.1% | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | -27.4% | — | ||
| Q3 24 | -25.8% | — | ||
| Q2 24 | -20.6% | — | ||
| Q1 24 | -30.4% | — |
净利率
CURI
KMTS
| Q4 25 | -19.7% | -145.3% | ||
| Q3 25 | -20.4% | -133.3% | ||
| Q2 25 | 4.1% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | -19.9% | — | ||
| Q3 24 | -24.3% | — | ||
| Q2 24 | -16.4% | — | ||
| Q1 24 | -42.0% | — |
每股收益(稀释后)
CURI
KMTS
| Q4 25 | $-0.07 | $-0.64 | ||
| Q3 25 | $-0.06 | $-0.50 | ||
| Q2 25 | $0.01 | — | ||
| Q1 25 | $0.01 | — | ||
| Q4 24 | $-0.05 | — | ||
| Q3 24 | $-0.06 | — | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.09 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $27.3M | $175.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $41.5M | $164.1M |
| 总资产 | $75.7M | $246.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CURI
KMTS
| Q4 25 | $27.3M | $175.4M | ||
| Q3 25 | $27.8M | $201.2M | ||
| Q2 25 | $28.1M | — | ||
| Q1 25 | $33.4M | — | ||
| Q4 24 | $32.1M | — | ||
| Q3 24 | $33.2M | — | ||
| Q2 24 | $39.5M | — | ||
| Q1 24 | $38.8M | — |
股东权益
CURI
KMTS
| Q4 25 | $41.5M | $164.1M | ||
| Q3 25 | $47.2M | $184.2M | ||
| Q2 25 | $49.8M | — | ||
| Q1 25 | $58.1M | — | ||
| Q4 24 | $57.8M | — | ||
| Q3 24 | $62.2M | — | ||
| Q2 24 | $64.8M | — | ||
| Q1 24 | $67.0M | — |
总资产
CURI
KMTS
| Q4 25 | $75.7M | $246.7M | ||
| Q3 25 | $74.7M | $266.3M | ||
| Q2 25 | $78.7M | — | ||
| Q1 25 | $85.3M | — | ||
| Q4 24 | $86.2M | — | ||
| Q3 24 | $87.6M | — | ||
| Q2 24 | $90.9M | — | ||
| Q1 24 | $94.6M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $4.0M | $-18.3M |
| 自由现金流经营现金流 - 资本支出 | $3.9M | $-25.6M |
| 自由现金流率自由现金流/营收 | 20.5% | -113.5% |
| 资本支出强度资本支出/营收 | 0.1% | 32.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
CURI
KMTS
| Q4 25 | $4.0M | $-18.3M | ||
| Q3 25 | $4.4M | $-26.3M | ||
| Q2 25 | $2.8M | — | ||
| Q1 25 | $1.9M | — | ||
| Q4 24 | $3.0M | — | ||
| Q3 24 | $2.3M | — | ||
| Q2 24 | $2.2M | — | ||
| Q1 24 | $666.0K | — |
自由现金流
CURI
KMTS
| Q4 25 | $3.9M | $-25.6M | ||
| Q3 25 | — | $-34.4M | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率
CURI
KMTS
| Q4 25 | 20.5% | -113.5% | ||
| Q3 25 | — | -177.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | 12.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度
CURI
KMTS
| Q4 25 | 0.1% | 32.2% | ||
| Q3 25 | 0.0% | 42.2% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率
CURI
KMTS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.56× | — | ||
| Q1 25 | 6.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图